Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Sameh who wrote (367)	2/18/1999 10:26:00 PM
From: Robert Dydo	Read Replies (1) \| Respond to of 572

The question here is where is the line between the upset and satisfaction. Xillix's sales are crucial for growth, hopeful expectations created by Olympus appear to be failing. Unless they will have sales of 4.5M in 4th quarter what would be the spark here? I have received e-mail in Sept.98 from IR that company is expecting Olympus to fully meet their targets. I also read of seasonal cycle of sales and stronger second half of the year. Third quarter made me less optimistic. I would love to be surprised by sales hitting 7.5M for 1998, but is this possible? Regards Robert